The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
A correction to this article has been published: Serafini et al., J. Exp. Med. 204 (7) 1729
Published online January 16, 2007
doi:10.1084/jem.20061115
The Journal of Experimental Medicine, Vol. 204, No. 1, 129-139
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Serafini et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4213K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Correction (v204,p1729)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serafini, M.
Right arrow Articles by Verfaillie, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serafini, M.
Right arrow Articles by Verfaillie, C. M.
Right arrowPubmed/NCBI databases
*GEO DataSet
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

 Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells

Marta Serafini1, Scott J. Dylla3, Masayuki Oki1, Yves Heremans1, Jakub Tolar2, Yuehua Jiang1, Shannon M. Buckley1,4, Beatriz Pelacho1, Terry C. Burns1, Sarah Frommer1, Derrick J. Rossi3, David Bryder3, Angela Panoskaltsis-Mortari2, Matthew J. O'Shaughnessy2, Molly Nelson-Holte1,4, Gabriel C. Fine1, Irving L. Weissman3, Bruce R. Blazar2, and Catherine M. Verfaillie1,4

1 Stem Cell Institute and 2 Cancer Center and Department of Pediatrics, Division of Hematology, Oncology, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN 55455
3 Department of Pathology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305
4 Department of Medicine, Stamcel Instituut Leuven, Katholieke Universiteit Leuven, Leuven 3000, Belgium

CORRESPONDENCE Catherine M. Verfaillie: catherine.verfaillie{at}med.kuleuven.be

For decades, in vitro expansion of transplantable hematopoietic stem cells (HSCs) has been an elusive goal. Here, we demonstrate that multipotent adult progenitor cells (MAPCs), isolated from green fluorescent protein (GFP)-transgenic mice and expanded in vitro for >40–80 population doublings, are capable of multilineage hematopoietic engraftment of immunodeficient mice. Among MAPC-derived GFP+CD45.2+ cells in the bone marrow of engrafted mice, HSCs were present that could radioprotect and reconstitute multilineage hematopoiesis in secondary and tertiary recipients, as well as myeloid and lymphoid hematopoietic progenitor subsets and functional GFP+ MAPC-derived lymphocytes that were functional. Although hematopoietic contribution by MAPCs was comparable to control KTLS HSCs, approximately 103-fold more MAPCs were required for efficient engraftment. Because GFP+ host-derived CD45.1+ cells were not observed, fusion is not likely to account for the generation of HSCs by MAPCs.

Abbreviations used: eGFP, enhanced GFP; ESC, embryonic stem cell; GVHD, graft-versus-host disease; HSC, hematopoietic stem cell; LT-HSC, long-term repopulating HSC; MAPC, multipotent adult progenitor cell; mESC, mouse ESC; NOD, nonobese diabetic; PB, peripheral blood.

M. Serafini and S.J. Dylla contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Cell replacement therapy—are MAPCs the answer?
Ruth Williams
J. Exp. Med. 2007 204: 4a. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS